Can you provide the last earnings date for PROMETHEUS BIOSCIENCES INC?
PROMETHEUS BIOSCIENCES INC (RXDX) last reported earnings on 5/9/2023.
PROMETHEUS BIOSCIENCES INC (RXDX) Earnings History & Surprises
NASDAQ:RXDX • US74349U1088
Current stock price
199.92 USD
+0.18 (+0.09%)
At close:
199.95 USD
+0.03 (+0.02%)
After Hours:
RXDX Earnings overview
Past quarterly earnings results for PROMETHEUS BIOSCIENCES INC (RXDX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q2 / 2023
- EPS Estimate
- -$0.95
- Revenue Estimate
- 616.08K
Last Reported
Most Recent- Release Date
- May 9, 2023
- Period
- Q1 / 2023
- EPS Reported
- -$0.86
- EPS Surprise
- 7.45%
- Revenue Surprise
- 113.46%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2023 | -0.86 | -0.93 | 7.45% | -4.88% | 1.105M | 517.65K | 113.46% | -71.80% |
| Q4 2022 | -0.90 | -0.94 | 4.21% | -16.88% | 653K | 590.692K | 10.55% | -37.03% |
| Q3 2022 | -0.90 | -0.92 | 2.44% | -28.57% | 968K | 654.503K | 47.90% | -3.78% |
| Q2 2022 | -0.86 | -0.93 | 7.69% | -75.51% | 1.269M | 520.649K | 143.73% | 289.26% |
| Q1 2022 | -0.82 | -0.81 | -1.40% | 50.90% | 3.919M | 669.293K | 485.54% | 415.66% |
| Q4 2021 | -0.77 | -0.69 | -11.30% | - | 1.037M | 554.584K | 86.99% | - |
| Q3 2021 | -0.70 | -0.60 | -17.11% | - | 1.006M | 357K | 181.79% | - |
| Q2 2021 | -0.49 | -0.40 | -23.60% | - | 326K | 153K | 113.07% | 82.12% |
| Q1 2021 | -1.67 | -0.38 | -341.31% | - | 760K | 204K | 272.55% | 233.33% |
| Q2 2020 | - | - | 179K | - | - | |||
| Q1 2020 | - | - | 228K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
5.45%
Max EPS beat (4)
7.69%
Min EPS beat (4)
2.44%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
78.91%
Max Revenue beat (4)
143.73%
Min Revenue beat (4)
10.55%
Analysis
In the last 4 quarters, RXDX has consistently beaten EPS estimates in all releases
RXDX has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, RXDX has beaten the EPS estimates by 5.4% on average.
In the last 4 quarters, RXDX has beaten the revenue estimates by 78.9% on average.
Related analysis
PROMETHEUS BIOSCIENCES INC / RXDX Earnings FAQ
Did RXDX stock beat earnings estimates in the most recent quarter?
PROMETHEUS BIOSCIENCES INC (RXDX) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does RXDX stock beat earnings estimates?
In the last 4 quarters, PROMETHEUS BIOSCIENCES INC (RXDX) has beaten EPS estimates in 4 out of 4 releases.